The Patent Finder

Vyripharm Enterprises, Inc.

Also on record
Records under this name other than the patents Vyripharm Enterprises, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Showing 1 to 8 of 8 · Back to Vyripharm Enterprises, Inc.

PatentTitleStatus Expires Confidence
US 8,741,864Gene Expression and Pain
Lapsed on the fee record
Ended Jun 3, 2026 · High confidence
Lapsed on the fee recordEnded Jun 3, 2026High confidence
US 10,683,502Oligonucleotide Decoys for the Treatment of Pain
Lapsed on the fee record
Ended Jun 16, 2024 · Medium confidence
Lapsed on the fee recordEnded Jun 16, 2024Medium confidence
US 9,290,762Gene Expression and Pain
Lapsed on the fee record
Ended Mar 22, 2024 · High confidence
Lapsed on the fee recordEnded Mar 22, 2024High confidence
US 8,093,225Gene Expression and Pain
Lapsed on the fee record
Ended Jan 10, 2024 · High confidence
Lapsed on the fee recordEnded Jan 10, 2024High confidence
US 10,434,178Formulations for the Delivery of Active Ingredients
Lapsed on the fee record
Ended Oct 8, 2023 · High confidence
Lapsed on the fee recordEnded Oct 8, 2023High confidence
US 7,943,591Gene Expression and Pain
Lapsed on the fee record
Ended May 17, 2023 · High confidence
Lapsed on the fee recordEnded May 17, 2023High confidence
US 10,287,583Oligonucleotide Decoys for the Treatment of Pain
Lapsed on the fee record
Ended May 14, 2023 · High confidence
Lapsed on the fee recordEnded May 14, 2023High confidence
US 9,700,624Formulations for the Delivery of Active Ingredients
Lapsed on the fee record
Ended Jul 11, 2021 · High confidence
Lapsed on the fee recordEnded Jul 11, 2021High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited